These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25200375)

  • 61. Charges billed to third parties for prescription drugs furnished by VA to a veteran for a nonservice-connected disability. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2010 Oct; 75(193):61621-3. PubMed ID: 20931727
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Barer M; Reid RJ
    Health Policy; 2011 Jul; 101(2):185-94. PubMed ID: 21255859
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Economic aspects of the new Spanish laws on pharmaceutical preparations.
    Antoñanzas F; Oliva J; Pinillos M; Juàrez C
    Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacy compliance with a prescription-drug discount program.
    Knapp KK; Law AV; Hitchman C
    N Engl J Med; 2002 Jul; 347(2):146-7; author reply 146-7. PubMed ID: 12110750
    [No Abstract]   [Full Text] [Related]  

  • 65. How to reduce out-of-pocket costs for prescription medications.
    Eliason MJ; Sontheimer RD
    Dermatol Online J; 2015 Jun; 21(6):. PubMed ID: 26158357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Copayments for medications. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2010 Jun; 75(110):32668-70. PubMed ID: 20524258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Hurley J; van Doorslaer E
    Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prescription drug coupons: evolution and need for regulation in direct-to-consumer advertising.
    Mackey TK; Yagi N; Liang BA
    Res Social Adm Pharm; 2014; 10(3):588-94. PubMed ID: 24120330
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surprising ways to cut your drug costs: even with insurance you might be paying too much.
    Consum Rep; 2013 Sep; 78(9):26-30. PubMed ID: 23930299
    [No Abstract]   [Full Text] [Related]  

  • 70. Medicare and state pharmaceutical legislation.
    Hanson K; Cauchi R
    NCSL Legisbrief; 2005; 13(35):1-2. PubMed ID: 16104077
    [No Abstract]   [Full Text] [Related]  

  • 71. Association of California's Prescription Drug Coupon Ban With Generic Drug Use.
    Rome BN; Gagne JJ; Kesselheim AS
    JAMA; 2021 Jun; 325(23):2399-2402. PubMed ID: 34129007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Engineering new strategies in specialty pharmacy management.
    Edlin M
    AHIP Cover; 2004; 45(5):34-9. PubMed ID: 15499743
    [No Abstract]   [Full Text] [Related]  

  • 73. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Evolution of pharmaceutical provision in the National Health System (1984-1994)].
    Crespo Sánchez-Eznarriaga B; Guerra Aguirre FJ
    Aten Primaria; 1995 Nov; 16(9):546-50. PubMed ID: 8562821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Summary of 1990 Medicaid drug rebate legislation. ASHP Government Affairs Division.
    Am J Hosp Pharm; 1991 Jan; 48(1):114-7. PubMed ID: 2000867
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Reference prices].
    Rey Abella ME
    Aten Primaria; 1999 Sep; 24(5):252-4. PubMed ID: 10590555
    [No Abstract]   [Full Text] [Related]  

  • 77. When patients cannot afford their medications.
    Tseng CW
    Am Fam Physician; 2004 Aug; 70(3):605-6, 608. PubMed ID: 15317446
    [No Abstract]   [Full Text] [Related]  

  • 78. The effect of a patient charge and a prescription regulation on the use of antihypertension drugs in Limburg, The Netherlands.
    Starmans B; Janssen R; Schepers M; Verkooijen M
    Health Policy; 1994 Jan; 26(3):191-206. PubMed ID: 10133131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Potentially excluded population from health coverage and health impact since Royal Decree 16/2012: The Central Catalonia experience].
    Álamo-Junquera D; Sala N; Millet JP; Ortega-Gutiérrez L; Planas-Giner A; Rovira C; Comet D
    Aten Primaria; 2015 Jan; 47(1):32-7. PubMed ID: 25241354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Shortage of supply of drugs in Spain. A health problem].
    Hernández Rodríguez MÁ; Orueta Sánchez R
    Aten Primaria; 2019 Dec; 51(10):599-601. PubMed ID: 31699458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.